SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000014272-21-000224
Filing Date
2021-10-27
Accepted
2021-10-27 11:26:21
Documents
88
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmy-20210930.htm   iXBRL 10-Q 3096509
2 EXHIBIT 31.A bmyex31a_20210930.htm EX-31.A 9724
3 EXHIBIT 31.B bmyex31b_20210930.htm EX-31.B 10071
4 EXHIBIT 32.A bmyex32a_20210930.htm EX-32.A 4229
5 EXHIBIT 32.B bmyex32b_20210930.htm EX-32.B 4188
  Complete submission text file 0000014272-21-000224.txt   13709163

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmy-20210930.xsd EX-101.SCH 68563
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmy-20210930_cal.xml EX-101.CAL 107950
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmy-20210930_def.xml EX-101.DEF 350721
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmy-20210930_lab.xml EX-101.LAB 868239
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmy-20210930_pre.xml EX-101.PRE 555752
11 EXTRACTED XBRL INSTANCE DOCUMENT bmy-20210930_htm.xml XML 3234784
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-01136 | Film No.: 211351543
SIC: 2834 Pharmaceutical Preparations